Clinical Trial: Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
Brief Summary: The purpose of this study is to investigate the efficacy and safety of oral phosphate (Z-521) in subjects with primary hypophosphatemic rickets.
Detailed Summary:
Sponsor: Zeria Pharmaceutical
Current Primary Outcome:
- Serum ALP level [ Time Frame: 6 month ]
- Serum phosphate level [ Time Frame: 6 month ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Zeria Pharmaceutical
Dates:
Date Received: November 7, 2010
Date Started: September 2010
Date Completion:
Last Updated: September 30, 2013
Last Verified: September 2013